46
Views
1
CrossRef citations to date
0
Altmetric
Systematic Review

Extended distal pancreatectomy in pancreatic cancer: is it justified? A systematic review of literature

, , ORCID Icon, , ORCID Icon & ORCID Icon
Pages 873-885 | Received 25 Nov 2022, Accepted 20 Apr 2023, Published online: 12 May 2023

References

  • Saad AM , TurkT, Al-HusseiniMJ, Abdel-RahmanO. Trends in pancreatic adenocarcinoma incidence and mortality in the United States in the last four decades; a SEER-based study. BMC Cancer18(1), 688 (2018).
  • Siegel RL , MillerKD, JemalA. Cancer statistics, 2020. CA Cancer J. Clin.70(1), 7–30 (2020).
  • Winer LK , DharVK, WimaKet al. The impact of tumor location on resection and survival for pancreatic ductal adenocarcinoma. J. Surg. Res.239, 60–66 (2019).
  • Meng R , ChenJ, D’OniseK, BarretoSG. Pancreatic ductal adenocarcinoma survival in South Australia: time trends and impact of tumour location. ANZ J. Surg.91(5), 921–926 (2021).
  • Barreto S , ShuklaP, ShrikhandeS. Tumors of the pancreatic body and tail. World J. Oncol.1(2), 52–65 (2010).
  • Zheng Z , WangM, TanCet al. Disparities in survival by stage after surgery between pancreatic head and body/tail in patients with nonmetastatic pancreatic cancer. PLOS ONE14(12), e0226726 (2019).
  • Birnbaum D , BertucciF, FinettiP, BirnbaumD, MamessierE. Head and body/tail pancreatic carcinomas are not the same tumors. Cancers11(4), 497 (2019).
  • Parikh PY , LillemoeKD. Surgical management of pancreatic cancer – distal pancreatectomy. Semin. Oncol.42(1), 110–122 (2015).
  • Luo G , JinK, ChengHet al. Prognosis of distal pancreatic cancers controlled by stage. Exp. Ther. Med.20(2), 1091–1097 (2020).
  • Artinyan A , SorianoPA, PrendergastC, LowT, EllenhornJD, KimJ. The anatomic location of pancreatic cancer is a prognostic factor for survival. HPB (Oxford)10(5), 371–376 (2008).
  • van Erning FN , MackayTM, vander Geest LGMet al. Association of the location of pancreatic ductal adenocarcinoma (head, body, tail) with tumor stage, treatment, and survival: a population-based analysis. Acta Oncol.57(12), 1655–1662 (2018).
  • Toomey P , HernandezJ, GolkarF, RossS, LubericeK, RosemurgyA. Pancreatic adenocarcinoma: complete tumor extirpation improves survival benefit despite larger tumors for patients who undergo distal pancreatectomy and splenectomy. J. Gastrointest. Surg.16(2), 376–381 (2012).
  • Ruess DA , MakowiecF, ChikhladzeSet al. The prognostic influence of intrapancreatic tumor location on survival after resection of pancreatic ductal adenocarcinoma. BMC Surg.15, 123 (2015).
  • Hank T , HinzU, TarantinoIet al. Validation of at least 1 mm as cut-off for resection margins for pancreatic adenocarcinoma of the body and tail. Br. J. Surg.105(9), 1171–1181 (2018).
  • Howard TJ , KrugJE, YuJet al. A margin-negative R0 resection accomplished with minimal postoperative complications is the surgeon’s contribution to long-term survival in pancreatic cancer. J. Gastrointest. Surg.10(10), 1338–1345; discussion 45–46 (2006).
  • Shrikhande SV , BarretoSG. Extended pancreatic resections and lymphadenectomy: an appraisal of the current evidence. World J. Gastrointest. Surg.2(2), 39–46 (2010).
  • Siripong A , ChungM, RichSE. Multivisceral pancreatic resections: worth the risk?Clin. Surg.3, 1–7 (2018).
  • Probst P , HuttnerFJ, MeydanOet al. Evidence map of pancreatic surgery – a living systematic review with meta-analyses by the International Study Group of Pancreatic Surgery (ISGPS). Surgery170(5), 1517–1524 (2021).
  • Hartwig W , VollmerCM, FingerhutAet al. Extended pancreatectomy in pancreatic ductal adenocarcinoma: definition and consensus of the International Study Group for Pancreatic Surgery (ISGPS). Surgery156(1), 1–14 (2014).
  • Page MJ , McKenzieJE, BossuytPMet al. The PRISMA 2020 statement: an updated guideline for reporting systematic reviews. BMJ372, n71 (2021).
  • Bassi C , MarchegianiG, DervenisCet al. The 2016 update of the International Study Group (ISGPS) definition and grading of postoperative pancreatic fistula: 11 years after. Surgery161(3), 584–591 (2017).
  • Dindo D , DemartinesN, ClavienPA. Classification of surgical complications: a new proposal with evaluation in a cohort of 6336 patients and results of a survey. Ann. Surg.240(2), 205–213 (2004).
  • Shoup M , ConlonKC, KlimstraD, BrennanMF. Is extended resection for adenocarcinoma of the body or tail of the pancreas justified?J. Gastrointest. Surg.7(8), 946–952; discussion 52 (2003).
  • Christein JD , KendrickML, IqbalCW, NagorneyDM, FarnellMB. Distal pancreatectomy for resectable adenocarcinoma of the body and tail of the pancreas. J. Gastrointest. Surg.9(7), 922–927 (2005).
  • Irani JL , AshleySW, BrooksDCet al. Distal pancreatectomy is not associated with increased perioperative morbidity when performed as part of a multivisceral resection. J. Gastrointest. Surg.12(12), 2177–2182 (2008).
  • Roch AM , SinghH, TurnerAPet al. Extended distal pancreatectomy for pancreatic adenocarcinoma with splenic vein thrombosis and/or adjacent organ invasion. Am. J. Surg.209(3), 564–569 (2015).
  • Kleeff J , DienerMK, Z’GraggenKet al. Distal pancreatectomy: risk factors for surgical failure in 302 consecutive cases. Ann. Surg.245(4), 573–582 (2007).
  • Malinka T , KleinF, AndreouA, PratschkeJ, BahraM. Distal pancreatectomy combined with multivisceral resection is associated with postoperative complication rates and survival comparable to those after standard procedures. J. Gastrointest. Surg.22(9), 1549–1556 (2018).
  • Seeliger H , ChristiansS, AngeleMKet al. Risk factors for surgical complications in distal pancreatectomy. Am. J. Surg.200(3), 311–317 (2010).
  • Beetz O , SarisinA, KaltenbornA, KlempnauerJ, WinklerM, GrannasG. Multivisceral resection for adenocarcinoma of the pancreatic body and tail – a retrospective single-center analysis. World J. Surg. Oncol.18(1), 218 (2020).
  • Goh BK , TanYM, CheowPCet al. Outcome of distal pancreatectomy for pancreatic adenocarcinoma. Dig. Surg.25(1), 32–38 (2008).
  • Paye F , MicelliLupinacci R, BachellierP, BoherJM, DelperoJR, FrenchSurgical Association. Distal pancreatectomy for pancreatic carcinoma in the era of multimodal treatment. Br. J. Surg.102(3), 229–236 (2015).
  • Panzeri F , MarchegianiG, MalleoGet al. Distal pancreatectomy associated with multivisceral resection: results from a single centre experience. Langenbecks Arch. Surg.402(3), 457–464 (2017).
  • Sahakyan MA , KleiveD, KazaryanAMet al. Extended laparoscopic distal pancreatectomy for adenocarcinoma in the body and tail of the pancreas: a single-center experience. Langenbecks Arch. Surg.403(8), 941–948 (2018).
  • Song KB , KwonJ, KimYWet al. Prognostic value of adjacent organ resection in patients with left-sided pancreatic ductal adenocarcinoma following distal pancreatectomy. J. Hepatobiliary Pancreat. Sci.26(6), 227–234 (2019).
  • Ramia JM , DelRio-Martin JV, Blanco-FernandezGet al. Distal pancreatectomy with multivisceral resection: a retrospective multicenter study – case series. Int. J. Surg.82, 123–129 (2020).
  • Sinn M , StrieflerJK, SinnBVet al. Does long-term survival in patients with pancreatic cancer really exist? Results from the CONKO-001 study. J. Surg. Oncol.108(6), 398–402 (2013).
  • Gooiker GA , vander Geest LG, WoutersMWet al. Quality improvement of pancreatic surgery by centralization in the western part of The Netherlands. Ann. Surg. Oncol.18(7), 1821–1829 (2011).
  • Hartel M , WenteMN, DiSebastiano P, FriessH, BuchlerMW. The role of extended resection in pancreatic adenocarcinoma: is there good evidence-based justification?Pancreatology4(6), 561–566 (2004).
  • Shukla PJ , BarretoSG, BediMet al. Peri-operative outcomes for pancreatoduodenectomy in India: a multi-centric study. HPB (Oxford)11(8), 638–644 (2009).
  • Wittmann D , HallWA, ChristiansKKet al. Impact of neoadjuvant chemoradiation on pathologic response in patients with localized pancreatic cancer. Front Oncol.10, 460 (2020).
  • Bergenfeldt M , MoesgaardF, BurcharthF. Curative resection for left-sided pancreatic malignancy. HPB (Oxford)8(3), 211–215 (2006).
  • Watanabe G , UshidaY, ObaAet al. Impact of tumor size on the outcomes of patients with resectable distal pancreatic cancer: lessons learned from a series of 158 radical resections. Ann. Surg. Oncol.29(1), 378–388 (2022).
  • Burdelski CM , ReehM, BogoevskiDet al. Multivisceral resections in pancreatic cancer: identification of risk factors. World J. Surg.35(12), 2756–2763 (2011).
  • Hartwig W , HackertT, HinzUet al. Multivisceral resection for pancreatic malignancies: risk-analysis and long-term outcome. Ann. Surg.250(1), 81–87 (2009).
  • Rosso E , LangellaS, AddeoPet al. A safe technique for radical antegrade modular pancreatosplenectomy with venous resection for pancreatic cancer. J. Am. Coll. Surg.217(5), e35–e39 (2013).
  • Klompmaker S , PetersNA, van HilstJet al. Outcomes and risk score for distal pancreatectomy with celiac axis resection (DP-CAR): an international multicenter analysis. Ann. Surg. Oncol.26(3), 772–781 (2019).
  • Altieri MS , YangJ, YinD, SpaniolasK, TalaminiM, PryorA. Thirty days are inadequate for assessing readmission following complex hepatopancreatobiliary procedures. Surg. Endosc.33(8), 2508–2516 (2019).
  • Karunakaran M , BarretoSG. Is enhancing recovery after pancreatic cancer surgery even possible?Chin. Clin. Oncol.10(5), 49 (2021).
  • Karunakaran M , BarretoSG, SinghMK, KapoorD, ChaudharyA. Deviations from a clinical pathway post pancreatoduodenectomy predict 90-day unplanned re-admission. Future Oncol.16(24), 1839–1849 (2020).
  • Kwon MA . Perioperative surgical home: a new scope for future anesthesiology. Korean J. Anesthesiol.71(3), 175–181 (2018).
  • Katz MH , SlackR, BrunoMet al. Outpatient virtual clinical encounters after complex surgery for cancer: a prospective pilot study of ‘TeleDischarge’. J. Surg. Res.202(1), 196–203 (2016).
  • de Rooij T , TolJA, van EijckCHet al. Outcomes of distal pancreatectomy for pancreatic ductal adenocarcinoma in The Netherlands: a nationwide retrospective analysis. Ann. Surg. Oncol.23(2), 585–591 (2016).
  • Hartwig W , GluthA, HinzUet al. Outcomes after extended pancreatectomy in patients with borderline resectable and locally advanced pancreatic cancer. Br. J. Surg.103(12), 1683–1694 (2016).
  • Sasson AR , HoffmanJP, RossEA, KaganSA, PingpankJF, EisenbergBL. En bloc resection for locally advanced cancer of the pancreas: is it worthwhile?J. Gastrointest. Surg.6(2), 147–157; discussion 57–58 (2002).
  • Gillen S , SchusterT, FriessH, KleeffJ. Palliative resections versus palliative bypass procedures in pancreatic cancer – a systematic review. Am. J. Surg.203(4), 496–502 (2012).
  • Zhou W , WangD, LouW. Current Role of Surgery in Pancreatic Cancer With Synchronous Liver Metastasis. Cancer Control.27(1), 1073274820976593 (2020). doi: 10.1177/1073274820976593.
  • Barreto SG , KleeffJ. Synchronous arterial resections in pancreatic cancer – still a matter of debate?Eur. J. Surg. Oncol.47(2), 480–482 (2021).
  • Oba A , HoF, BaoQR, Al-MusawiMH, SchulickRD, ChiaroMD. Neoadjuvant treatment in pancreatic cancer. Front Oncol.10, 245 (2020). doi: 10.3389/fonc.2020.00245.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.